Individualized neurofeedback treatment for ADHD
Examine the Effectiveness of Individualized Alpha Neurofeedback for Children With ADHD, a Triple-blinded Randomised Control Trial
This study is testing if personalized brain training can help children with ADHD feel better by comparing it to a fake treatment over four weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 5 Years to 13 Years |
| Sex | All |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Trial ID | NCT06142786 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of individualized alpha neurofeedback training for children diagnosed with ADHD. A total of 120 participants will be randomly assigned to either a neurofeedback group or a sham feedback group, undergoing training twice a week for four weeks. The study aims to evaluate changes in ADHD symptoms through cognitive and EEG assessments conducted before and after the intervention, as well as follow-ups at 12 months. The trial seeks to address previous limitations in neurofeedback studies by utilizing more effective neurophysiological markers.
Who should consider this trial
Good fit: Ideal candidates are children who meet the DSM-IV-TR criteria for ADHD and are not currently undergoing other treatments.
Not a fit: Patients with comorbid psychiatric disorders or significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological treatment option for children with ADHD, potentially reducing reliance on medication.
How similar studies have performed: Previous studies have shown mixed results regarding neurofeedback for ADHD, indicating that while some approaches have been promising, this specific method is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fulfilment of the DSM-IV-TR criteria for ADHD * No intention to use new medication/change dosage/join new non-pharmacological treatment program during the intervention period. Exclusion Criteria: * Diagnosis of cerebral palsy/ history of structural brain abnormalities on CT/ MRI; * full-scale IQ score (FSIQ) \< 70; * A history of seizure or prior electroencephalogram abnormalities related to epilepsy. * Having comorbid psychiatric disorders, including schizophrenia or schizoaffective disorder, bipolar disorder, borderline personality disorder, epilepsy, or traumatic brain injury; current substance abuse or dependence * Planned other behavioural/durg treatment during the intervention period
Where this trial is running
Hong Kong, Hong Kong
- Li Ka Shing Faculty of Medicine — Hong Kong, Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Winnie WY Tso, MBBS — The University of Hong Kong
- Study coordinator: Yuliang Wang, Mphil
- Email: lornewang@connect.hku.hk
- Phone: +852 51342479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.